Timing of Development of Symptomatic Brain Metastases from Non-Small Cell Lung Cancer: Impact on Symptoms, Treatment, and Survival in the Era of Molecular Treatments

Objective: We attempted to analyze whether early presentation with brain metastases (BM) represents a poor prognostic factor in patients with non-small cell lung cancer (NSCLC), which should guide the treatment team towards less intensified therapy. Patients and methods: In a retrospective bi-centri...

Full description

Bibliographic Details
Main Authors: Stephanie T. Jünger, Petra Schödel, Daniel Ruess, Maximilian Ruge, Julia-Sarita Brand, Maike Wittersheim, Marie-Lisa Eich, Nils-Ole Schmidt, Roland Goldbrunner, Stefan Grau, Martin Proescholdt
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/12/3618